The Role of Residual Tumor Resection in Patients with Metastatic Renal Cell Carcinoma and Partial Remission following Immunochemotherapy
- 1 May 2007
- journal article
- Published by Elsevier in European Urology Supplements
- Vol. 6 (10) , 641-645
- https://doi.org/10.1016/j.eursup.2007.03.003
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Nephrectomy Followed by Interferon Alfa-2b Compared with Interferon Alfa-2b Alone for Metastatic Renal-Cell CancerNew England Journal of Medicine, 2001
- Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trialThe Lancet, 2001
- RENAL CELL CARCINOMA: MANAGEMENT OF ADVANCED DISEASEJournal of Urology, 1999
- Metastasectomy in Renal Cell Carcinoma: A Multicenter Retrospective AnalysisEuropean Urology, 1999
- Natural history and therapy of metastatic renal cell carcinomaCancer, 1997
- Renal Cell Carcinoma Metastatic to the Lung: Potential Benefit in the Combination of Biological Therapy and SurgeryJournal of Urology, 1996
- Surgeon's role in the management of solitary renal cell carcinoma metastases occurring subsequent to initial curative nephrectomy: An institutional reviewAnnals of Surgical Oncology, 1994
- Surgery Following Response to Interfergn-α-Baseb Therapy for Residual Renal Cell CarcinomaJournal of Urology, 1993
- Surgical Resection Following Interleukin 2 Therapy for Metastatic Renal Cell Carcinoma Prolongs RemissionArchives of Surgery, 1992
- Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapyCancer, 1992